ArticleNeurology2026
Neurology Wait Times After Primary Care or Emergency Department Visits Among the Commercially Insured Population in the United States: 2019-2023.
Article in Neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesDespite the importance of timely access to ambulatory specialty care, data regarding wait times to neurologists are largely lacking. This study examines wait times, and drivers of wait times, for new neurology office visits among commercially insured persons in the United States.
methodsWe conducted a retrospective, repeated cross-sectional study using 2019-2023 data from the Merative MarketScan Commercial Database of approximately 20 million annual US enrollees. Enrollees with a new neurology visit, a primary care or emergency department (ED) visit in the prior 365 days, and continuous enrollment were included. The outcome was wait time in days for a new neurology visit following a primary care or ED visit. Mean (SD) and median (interquartile range [IQR]) wait times were reported by sex, race, neurologic condition, insurance type, and geographic region. Wait times were modeled using generalized estimating equations, clustering within metropolitan statistical areas (MSAs), and adjusted for demographic, insurance, clinical, and geographic variables.
resultsBetween 2019 and 2023, 114,034 enrollees met our inclusion criteria, the mean age was 42.1 (SD = 16.1), and 65.6% were female. The average wait time for a new neurology visit was 49.7 days (SD = 65.4), and the median wait was 25.0 days (IQR = 9-62). Estimated wait times were shorter for female patients, compared with male patients (-7.0 days; 95% CI -7.8 to -6.2), and for stroke (-8.2 days; 95% CI -9.5 to -6.9), dizziness or vertigo (-7.8 days; 95% CI -10.4 to -5.1), and traumatic brain injury (-6.5 days; 95% CI -8.0 to -5.1) and longer for multiple sclerosis (+4.0 days; 95% CI 2.0-6.1). The Northeast Census region had the longest waits (+4.6 days; 95% CI 3.3-6.0). The proportion of non-Hispanic White race within a MSA was associated with reduced wait times (-0.2 days per MSA percent White; 95% CI -0.2 to -0.1). Enrollees with consumer driven health plans had the shortest wait times (-2.4 days; 95% CI -3.6 to -1.2). Neurologist density/100,000 enrollees was not associated with wait time (0.0 days: 95% CI -0.01 to 0.00). DISCUSSION: Wait times for new neurology appointments vary by sex, neurologic condition, insurance type, and geographic level variables.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.